Key facts
- Jon Faiz Kayyem filed SCHEDULE 13D/A for Inhibrx Biosciences, Inc. Common Stock, par value $0.0001 per share (INBX).
- Disclosed ownership: 7.9%.
- Date of event: 03 Jun 2024.
Jon Faiz Kayyem - 03 Jun 2024 SCHEDULE 13D/A Report for Inhibrx Biosciences, Inc. Common Stock, par value $0.0001 per share (INBX)
- Filing Manager
- Jon Faiz Kayyem
- Reporting Manager
- Jon Faiz Kayyem
- Symbol
- INBX
- Shares outstanding
- 14,544,886 shares
- Disclosed Ownership
- 1,149,046 shares
- Ownership
- 7.9%
- Form type
- SCHEDULE 13D/A
- Filing time
- 26 Feb 2025, 16:26:18 UTC
- Date of event
- 03 Jun 2024
- SEC
- View on sec.gov
Key filing fact
Jon Faiz Kayyem disclosed 7.9% ownership in Inhibrx Biosciences, Inc. Common Stock, par value $0.0001 per share (INBX) on 03 Jun 2024.
Change
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 26 Feb 2025, 16:26.
Research use
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Reporting managers (2)
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| The Jon F. Kayyem and Paige Gates-Kayyem Family Trust | 3.5% | 509,360 | 509,360 | 0 | /s/ Jon Faiz Kayyem | Jon Faiz Kayyem, Trustee | 0001821293 |
| Jon Faiz Kayyem | 7.9% | 1,149,046 | 0 | 1,149,046 | /s/ Jon Faiz Kayyem | Jon Faiz Kayyem | 0001366268 |
CIK / CUSIP context first